|
Session 114
Poster Abstracts
Biological Determinants of Disease Progression and Long-Term Outcomes of Antiretroviral Therapy in Children and Adolescents
Monday, 1:30 - 3:30 pm
Poster Hall |
| 679 |
Effect of MBL2 Alleles on HIV-1 Disease Progression of the Children in the United States
Kumud Singh*1, A Lieser2, M Hughes3, C Alvero3, and S Spector1
1Univ of California, San Diego, US; 2Univ of California Sch of Med, Irvine, US; and 3Harvard Sch of Publ Hlth, Boston, MA, US |
| 680 |
Functional Consequences of Immunogenetic Factors Determining HIV Progression in a Pediatric HIV-1 Cohort Infected with a Mono-phyletic HIV Strain
Massimo Amicosante*1, R D'Arrigo1, G Castelli-Gattinara2, A Salerno3, C Montesano1, G Rezza4, M Mehdi5, L Perrin6, C F Perno1, and V Colizzi1
1Univ Tor Vergata, Rome, Italy; 2Bambino Gesù Children's Hosp, Rome, Italy; 3Univ of Palermo, Italy; 4Inst Superiore di Sanità, Rome, Italy; 5Al Arab Med Univ, Benghazi, Lybia; and 6Geneva Univ Hosp, Switzerland |
| 681 |
Long-term Decay of HIV-1 Cellular Reservoir in HIV-1 Infected Childen Treated with Highly Active Antiretroviral Therapy
M Zanchetta1, S Walker2, N Burighel1, D Bellanova1, O Rampon3, C Giaquinto3, and Anita De Rossi*1
1AIDS Reference Ctr, Univ of Padova, Italy; 2Med Res Council, London, UK; and 3Univ of Padova, Italy |
682
 |
High Frequency of Mutations Associated to Antiretroviral Drug Resistance in Recently Diagnosed HIV-infected Children
Moira Vignoles*1, S González-Ayala2, G Barboni3, M R Agosti2, V Giraudi3, and H Salomón1
1Argentinian Natl Reference Ctr for AIDS, Buenos Aires; 2Superiora Sor María Ludovica Hosp, La Plata, Argentina; and 3“Dr. Pedro de Elizalde” Children Hosp, Buenos Aires, Argentina |
683
|
Long-term Clinical and Biological Outcomes in Children Vertically Infected with HIV
Catherine Dollfus*1, J Le Chenadec2, A Faye3, S Blanche4, C Rouzioux4, J Tricoire5, G Firtion6, E Lachassinne7, J Warszawski8, and the French Pediatric Cohort EPF
1Hosp Trousseau, AP-HP, Paris, France; 2INSERM U569, Univ Hosp Bicêtre, Le Kremlin-Bicêtre, France; 3Hosp Robert Debré, Paris, France; 4Ctr Hosp Univ Necker, Paris, France; 5Hosp Paule De Viguier, Toulouse, France; 6Maternité Port Royal, Paris, France; 7Hosp Jean Verdier, Bondy, France; and 8INSERM U569, Bicetre Hosp, Le Kremlin-Bicêtre, France |
| 684 |
Virologic and Immunologic Outcomes and Adherence in Adolescents Initiating HAART: 3-Year Follow-up Data from PACTG 381
Bret J. Rudy*2, P Flynn1, J Lindsey3, J Lathey4, S Douglas2, M Hughes3, S Spector5, and the Pediatric AIDS Clinical Trials Group 381 Study Team
1St Jude Children's Res Hosp, Memphis, TN, US; 2Children's Hosp of Philadelphia and Univ of Pennsylvania Sch of Med, US; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4SeraCare BioSvcs, Gaithersburg, MD, US; and 5Univ of California, San Diego, US |
|
